|

ATG Clinical Trials

3 actively recruiting trials across 1 location

Also known as: Thymoglobulin

Pipeline

Phase 2: 1Phase 1/2: 1Phase 2/3: 1

Top Sponsors

  • Nantes University Hospital1
  • Hospital Israelita Albert Einstein1
  • Alice Bertaina1

Indications

  • Cancer2
  • CKD Stage 41
  • SLE Nephritis1
  • FSGS1
  • SIOD1

Other2 trials

Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
Phase 2/3
Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT
Phase 2

Palo Alto, California1 trial

Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor

Lucile Packard Children's Hospital

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.